FDA has approved Verquvo for patients with symptomatic chronic heart failure
The U.S. Food and Drug Administration ( FDA ) has approved soluble guanylate cyclase ( sGC ) stimulator Vericiguat under the brand name Verquvo.
Vericiguat 2.5 mg, 5 mg, and 10 mg is indicated to re ...
read article